Novartis vs AstraZeneca

Novartis leads AstraZeneca by 13.0 points on the Fameproof index, and wins 3 of the three models. Measured weekly: 24 prompts × 4 runs = 96 answers per model.

Novartis
Novartis
Pharmaceuticals
29.7/100
Rank 67 on the companies board
AstraZeneca
AstraZeneca
Pharmaceuticals
16.7/100
Rank 88 on the companies board
Novartis
Per-model score
AstraZeneca
27.0
Claude
14.0
20.0
ChatGPT
18.0
42.0
Gemini
18.0
30-day movement
−2.0
Change
−0.6
Last 7 runs
Answer quality
17%
Claude mention rate
2%
7%
ChatGPT mention rate
3%
40%
Gemini mention rate
4%
7%
Claude prominence
0%
2%
ChatGPT prominence
1%
14%
Gemini prominence
0%

Questions about this comparison

Who do AI models mention more, Novartis or AstraZeneca?

Novartis. It scores 29.7 on the Fameproof index against 16.7 for AstraZeneca — a lead of 13.0 points, measured across Claude and ChatGPT and Gemini in the run of 26 October 2026.

How is the Novartis vs AstraZeneca comparison measured?

Both are asked about with the same panel of category questions — never questions naming them — repeated on every model each week. The score combines how often each is named, how early in the answer, how much of the topic is covered and how consistent the result is.

Both are ranked on the Company AI Visibility board. Prominence reflects how early in an answer the model names them; mention rate is how often it names them at all. How the score is built.

Check my company